CORPORATE CULTURE OF QUALITY - · PDF fileCONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP....
Transcript of CORPORATE CULTURE OF QUALITY - · PDF fileCONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP....
CONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED.
CORPORATE
CULTURE OF
QUALITY
David L. Chesney, Vice President, Strategic
Compliance Services
PAREXEL Consulting, Waltham, MA USA
+1-781-434-4092
IVT Quality Metrics and Management
Week, Coronado, CA
February 22-24, 2016
CONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED.
QUALITY +
CULTURE = ??
It would appear we need to define some
terms…..
2
CONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED. /
QUALITY DEFINED
• Definitions abound! The editors of Quality Digest say that defining
the word "quality" is "no simple endeavor."
• Juran said quality meant “fitness for use”
• Deming said only the “customer” can define quality (begs a new
question, “who is the customer”?)
• ISO Definition: “Quality is the totality of features and
characteristics of a product or service that bear on its ability to
satisfy stated or implied needs.”
• The FDCA Sections 501(b) and (c) define adulteration of compendial
and noncompendial drugs, respectively, in part, as
– [501(b)] “…(its) strength differs from, or its quality or purity falls below,
the standard set forth in (the applicable) compendium…” or
– 501(c)] “…If it is not subject to the provisions of paragraph (b) of this
section and its strength differs from, or its purity or quality falls below,
that which it purports or is represented to possess”
3
CONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED. /
THE TERM “QUALITY” IS USED IN VARYING WAYS IN
OUR INDUSTRY• Sometimes it means “floor level” GMP compliance
• 21 CFR 210.1(a) states in part “The regulations set forth in this part …contain the
minimum current good manufacturing practice for methods to be used in, and the
facilities or controls to be used for, the manufacture, processing, packing, or holding of a
drug …” (emphasis added)
• Sometimes it means elevating the standard to the maximum feasible level
• Sometimes it refers to attributes of a product
• Sometimes it refers to the Quality Unit , as in “Let’s ask Quality what they
think…”
• Sometimes it refers to a mindset or approach to the job one is doing
• “Big Q” – the attributes of quality of the product
• “Little q” – Quality Operations; the job of the Quality Unit
4
CONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED. /
QUALITY IS NOT EASY TO DEFINE!
• For purposes of this discussion, let’s use:
• A “Quality” drug product always meets specifications that are designed
to ensure proper clinical performance, and is manufactured under
conditions that are controlled to assure consistent correct results.
5
CONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED. /
“QUALITY” IS NOT EASY TO SELL TO PHARMACEUTICAL
COMPANY LEADERSHIP – WHY? --
• Because, for the most part, it does not drive sales in this industry.
• The case usually made for a strong quality system involves
primarily avoidance of adverse consequences:
• We’ll reduce deviations
• We’ll have less defects and rejections
• We’ll have fewer recalls, complaints and adverse publicity
• We’ll have less regulatory problems and associated costs
• You never hear anyone say “If we have a better quality system we
will sell more products!”
• In other industries that works: Cars, consumer electronics,
barbeque grills, furniture, etc. Pharmaceuticals? Not so much.
6
CONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED. /
IS THAT REALLY TRUE??!
• Probably. Some possibly controversial thoughts:
• Those in this room are among the most highly astute consumers of
pharmaceutical products. But when we get prescriptions filled, most likely we
direct little more than idle curiosity toward who made the product.
• Even if we know who made it, if we have never worked there and we don’t work
for FDA, we probably don’t really have a clue how good their quality systems
are. But we purchase and use the product anyway.
• The general public is even less aware and less able to judge pharmaceutical
quality than we are. So how could it have much influence on purchase
decisions?
• We don’t buy cars, noise cancelling headsets, appliances, computers, etc. that
way. We read Consumer Reports, research the product on line, or rely on our
own judgment of the quality of the product and reputation of the manufacturer.
• That translates into sales. Ask Bose, Weber Grill Company, top car companies,
and Apple if their investment in quality pays dividends. Then ask your CEO.
7
CONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED. /
WHO “OWNS” QUALITY?
• Everyone. No exceptions.
• Who owns quality operations? The Quality Unit. This includes:
• Evaluation of materials
• Evaluation of Standard Operating Procedures
• Evaluation of changes to GMP governed issues, operations, and documents
• Evaluation of the adequacy of qualification and validation activities
• Evaluation of the adherence to required GMP controls
• Evaluation of the adherence to company standards and internal controls that may go
beyond what is required by GMP
• Batch release, including whether deviations have been thoroughly investigated and the
impact of their occurrence has been properly evaluated
• Other activities within the scope of authority of the Quality Unit under GMP and company
procedures
8
CONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED. /
CORPORATE CULTURE DEFINED
• There are many different definitions; a sampling:
• From investopedia.com:
• “The beliefs and behaviors that determine how a company's employees and
management interact and handle outside business transactions. Often, corporate culture
is implied, not expressly defined, and develops organically over time from the cumulative
traits of the people the company hires. A company's culture will be reflected in its dress
code, business hours, office setup, employee benefits, turnover, hiring decisions,
treatment of clients, client satisfaction and every other aspect of operations.”
• From wikipedia.com:
• “Organizational culture is the behavior of humans who are part of an organization and the
meanings that the people attach to their actions. Culture includes the organization
values, visions, norms, working language, systems, symbols, beliefs, and habits. It is also
the pattern of such collective behaviors and assumptions that are taught to new
organizational members as a way of perceiving, and even thinking and feeling.
Organizational culture affects the way people and groups interact with each other, with
clients, and with stakeholders.”
9
CONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED. /
CORPORATE CULTURE DEFINED
• Ravasi, D., Schultz, M. (2006), Responding to organizational identity
threats: exploring the role of organizational culture, Academy of
Management Journal, Vol.49, No.3, pp. 433–458:
• “Organizational culture is a set of shared mental assumptions that guide interpretation
and action in organizations by defining appropriate behavior for various situations.”
• One of the more thought-provoking definitions is from Needle,
David (2004). Business in Context: An Introduction to Business and
Its Environment:
• “Corporate culture…refers to those cultures deliberately created by management to
achieve specific strategic ends.” (emphasis added)
• If culture is “deliberately created” it follows that it can be
deliberately changed when necessary. But how? And how do you
know it is necessary?
10
CONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED. /
OUR EXPERIENCE
• For better or worse, our consulting practice puts us in frequent contact
with companies that have been the subject of some sort of regulatory
enforcement crisis, failed PAI, Warning Letter, seizure, consent decree of
permanent injunction, data integrity problem, etc. etc. etc.
• In virtually every case, at some point, someone will say something like…:
• “Our culture does not support quality”
• “The issue is cultural here, it runs deep”
• “We need to change the culture if we are going to fix this”
• The need to address the culture is frequently recognized but rarely acted
upon in a deliberate way, though sometimes it happens anyway
• What follows is the result of having observed this process play out many
times in many places
11
CONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED. /
FIVE REASONS COMPANIES DEVELOP A “QUALITY
CULTURE PROBLEM”
1. Benign ignorance. Symptoms include:
A. Focus on clinical trial progress, particularly when successful, and ignoring need to
assure sound manufacturing processes and process understanding
B. Leadership that has no experience running manufacturing operations and simply has
no idea of what it takes. Often seen in companies that mature from a development
focused environment to one where someone decides to commercialize something
themselves rather than sell it off and start over.
C. “Virtual” organizations that think if you outsource everything you have no responsibility
for anything other than to sit back and reap the rewards
2. Pipeline panic. Symptoms include two mirror images:
A. The blockbuster product that has sustained us for years is going off patent and we
have nothing coming down the pike to replace it. We have to push product out the
door while we still can. Or alternatively:
B. Our new product is a blockbuster, we need to shove as much of it out there as fast as
possible to satisfy impatient investors, recoup our development costs and drive up the
stock price. Don’t slow that process down for “bureaucratic reasons”!
12
CONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED. /
FIVE REASONS COMPANIES DEVELOP A “QUALITY
CULTURE PROBLEM”
3. False sense of regulatory invulnerability, which may be caused
by these or other things:
A. Our product is in short supply
B. Our product is high medical need (or A and B together)
C. Our product is the only modality for use in this disease condition
D. FDA has inspected us several times over many years and never found anything
seriously wrong (abdication of quality responsibility to the regulator)
E. We have small numbers of complaints and adverse events reported
F. Our product has been sold in Whoknowswhereistan for years with no issues
4. Egotism and arrogance. Exemplified by:
A. We are the recognized industry leaders! We set the standard!
B. The regulators do not understand our process!
C. We are unique!
13
CONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED. /
TOP FIVE REASONS COMPANIES DEVELOP A “QUALITY
CULTURE PROBLEM”
5. The well worn “science versus compliance” debate
A. We have the science to support this, who needs those pencil headed bureaucrats and
their documentation rules!
B. Following GMP impedes creativity and slows the advance of science!
C. We are the experts, don’t tell us how to do our job!
D. “Everybody knows that”!
Some thoughts on this to bear in mind:
• Compliance without good science behind it is an empty exercise and basically worthless.
• No matter how good the science, you cannot test compliance into a product, you must
build it in, which requires the application of sound quality management practices, and,
yes, that involves compliance.
• You need both. There is no debate.
14
CONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED. /
TOP FIVE CHARACTERISTICS OF COMPANIES WITH A
CULTURE THAT SUPPORTS QUALITY
1. Focus on the patient
• Patient needs and patient risk is in the forefront of every key decision
• Employees understand indications for use of products and how quality attributes
influence product performance and patient safety. Litmus test: Ask an employee what the
product he/she is working on is used for.
• Patient safety is the paramount driver of quality decisions (batch release, deviation
investigation approach, CAPA, etc.)
• There is continuous messaging from leadership about the importance of the patient
2. Everyone is held accountable for “Quality”; the Quality Unit is
held accountable for quality operations (tasks and activities) in
addition to “Quality” in the larger sense of the word
3. Top management supports the quality function “philosophically
and materially”
• Authority is commensurate with responsibility
15
CONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED. /
TOP FIVE CHARACTERISTICS OF COMPANIES WITH A
CULTURE THAT SUPPORTS QUALITY
4. Quality Organization strongly positioned in the corporate
hierarchy
• The Quality organization is at a peer level to other operational units
• Strong, consistent shop floor presence of Quality Unit on all operational shifts
• Personnel in the Quality organization are respected for their knowledge and
professionalism, even when there are disagreements
• Litmus test: Check the corporate web site. Look at the featured members of the senior
leadership team. Is the Head of Quality among them? Individuals featured here
communicate to the outside world which parts of the organization are deemed critical to
its success.
• Quality Head reports to the same level as Head of Manufacturing Operations, Regulatory
Affairs, and other key senior leaders of the company.
5. Actions are aligned with policies about quality
• “The standard of quality you release to the market is your real standard”
• Litmus test: Re-read your corporate quality statement. Does it align with your daily
experience?16
CONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED. /
SOME OTHER INDICATORS OF A STRONG QUALITY
CULTURE
• CAPAs are raised proactively in certain cases, before there is a deviation,
failure or something that needs a fix, to prevent ever having the problem in
the first place.
• Quality Unit personnel are sought out for their opinions, as trusted
advisors, not adversaries
• Manufacturing personnel down to the lowest level are empowered to take
necessary corrective actions, including halting production, when things go
wrong. And, when necessary, they do, without waiting for the Quality Unit
to tell them to.
• Managers at all levels are visible, frequently, on the shop floor. They talk to
working level employees and have first hand knowledge of conditions and
emerging issues. Quality Unit personnel are on the floor on all shifts.
• The test of a corrective action is how well it worked, not just that an
objective was met within an established time frame.
17
CONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED. /
INCENTIVE SYSTEMS AND THEIR INFLUENCE ON
CORPORATE CULTURE
• “What gets measured gets done” (an old maxim from the
Management by Objectives approach, attributed to several people)
• What gets tangibly incentivized gets done first!
• Systems that incentivize “pushing product out the door” or which
have unbalanced objectives that fail to consider quality and
compliance can quickly drive behaviors in the wrong direction
• The answer is strategic harmonization of goals across the
organization, with quality receiving equal consideration to other
success factors.
18
CONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED. /
EXAMPLE OF A STRATEGICALLY HARMONIZED
OBJECTIVE
• “Deliver a successful PAI for Product X”
• Meets business objectives
• Easily measurable – in fact, binary (yes/no)!
• Meets needs of patients and health care practitioners by providing access to a new
modality
• Satisfies investor concerns
• Each organizational element, Manufacturing Operations, Quality, Regulatory Affairs, QC,
Facilities Engineering, etc. needs to perform certain tasks in furtherance of the objective.
Tactics will differ horizontally across the organization and even vertically within
departments (individual contributors will do different things than their supervisors, mid
level managers and senior managers) but all share in the end result.
• Allows no room for compromise on quality and compliance objectives since failing to
meet these will result in the objective not being met.
19
CONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED. /
HOW WELL MEANING OBJECTIVES CAN HAVE
UNINTENDED CONSEQUENCES
• “Reduce deviations by 20% from last year”
• Sounds good at first; hard to argue with…but…
• Can incentivize under-reporting of things that go wrong in the interest of meeting the
objective
• Does not take into account production variables:
– Last year we made 100 batches and had 1000 recorded deviations
– This year we made 200 batches and had 1100 recorded deviations
» We failed to “reduce deviations by 20%” but we cut the rate of deviations from 10 per
batch to 5.5 per batch
• Does not take into account seriousness of deviations that do occur, root cause, whether
we had repeating deviations, etc.
• Don’t throw the baby out with the bath water, just be careful what you are actually
incentivizing.
• Use metrics that matter, and consider the law of unintended consequences
20
EXCELLENCE
COMPETENCE
UNDERSTANDING
AWARENESS
INNOCENCE
Quality Culture Maturity Model
Quality mainly outsourced to
regulators
I’m good because I passed
the last inspection
I’m good because I passed
the last inspection
21 | ICH Q10 | Juan Andres | Process Improvement
Source:
EXCELLENCE
COMPETENCE
UNDERSTANDING
AWARENESS
INNOCENCE
Quality Culture Maturity Model
Quality mainly outsourced to
regulators
Quality Unit will identify the issues
Quality Systems and metrics reveal
reality, and drive action
Quality mindset in all functions
Design Quality in & anticipate issues
Competitive advantage through
prevention of Quality issues
I’m good because I passed
the last inspection
I’m good because I passed
the last inspection
It’s good as long as Quality
approves it
It’s good as long as Quality
approves it
We review Q. along with other
aspects of the business
We review Q. along with other
aspects of the business
Tolerance to problems and
mistakes is minimal
Tolerance to problems and
mistakes is minimal
Failure to integrate Quality is
not even an option
Failure to integrate Quality is
not even an option
22 | ICH Q10 | Juan Andres | Process Improvement
Source:
CONFIDENTIAL ©2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED. /
ACTION PLAN FOR
ENHANCING
CORPORATE QUALITY
CULTURE
1. Publish a strong corporate quality vision and
mission statement.
2. Back it up with consistent actions that send
the message that you mean what you say.
Really.
3. Make patients who use your products visible
to your employees. Reinforce this often. Use
posters, videos, even focus group
discussions. Get the face of the patient in
front of your people.
4. Position the Quality Organization at the
highest level, at a minimum as a peer to other
operational units in the company.
5. Empower the Quality Organization with
authority commensurate with responsibility.
6. Put a Quality presence “on the floor” in
manufacturing and laboratory areas. Engage
QA and operations personnel on issues in real
time.
7. Hold the Quality Organization accountable to
high standards of good science, sound logic
and reasonable theories of regulatory
compliance. Avoid being pedantic or nit-picky.
23